6533b7d9fe1ef96bd126cb97
RESEARCH PRODUCT
Long-Term Safety of Tiotropium/Olodaterol Respimat in Patients with Moderate-to-Very Severe COPD and Renal Impairment in the TONADO Studies
Roland BuhlUlrich BothnerS StieglitzL LoaizaEric DeromCraig LaforceMatthias Trampischsubject
Pulmonary and Respiratory Medicinemedicine.medical_specialtyRespimatbusiness.industryInternal medicinemedicineTiotropium-olodaterolIn patientLong term safetySevere copdbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2018-02-21 | Pneumologie |